Centaurus Financial, Inc. Standard Biotools Inc. Transaction History
Centaurus Financial, Inc.
- $1.37 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding LAB
# of Institutions
148Shares Held
269MCall Options Held
422KPut Options Held
40.7K-
Casdin Capital, LLC New York, NY64MShares$132 Million9.8% of portfolio
-
Viking Global Investors LP58.7MShares$121 Million0.41% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$44.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$33 Million0.0% of portfolio
-
Morgan Stanley New York, NY12.9MShares$26.6 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $162M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...